회춘

Life Biosciences this week began the first FDA‑approved human trial of an anti‑ageing therapy, ER‑100, targeting optic‑nerve cells in glaucoma patients. The approach uses cellular… 6월 11, 2026

Scientists and startups are converging on two very different routes to extend life: biological rejuvenation and digital afterlives. This article surveys the real progress, remaini… 11월 28, 2025